Market Place
Sourcing Support
Bryn Pharma Starts PK/PD Trial with Upgraded Nasal Spray
25 Jun 2025 //
GLOBENEWSWIRE
Bryn Pharma Appoints Joshua Ziel as Chief Executive Officer
24 Oct 2024 //
GLOBENEWSWIRE
Positive Results from Study for Bryn`s Epinephrine Nasal Spray Published
12 Dec 2023 //
PR NEWSWIRE
Bryn Pharma to Present Data Supporting Use of Epinephrine Nasal Spray
09 Nov 2023 //
PR NEWSWIRE
Bryn Pharma Announces Expansion of Leadership Team
25 Jul 2023 //
BUSINESSWIRE
Bryn Pharma Expands Corporate Leadership with Three New Executive
02 May 2023 //
BUSINESSWIRE
Pharmaceutical Industry Thought Leader James Borneman Joins Bryn Pharma as COO
27 Mar 2023 //
BUSINESSWIRE
Bryn Pharma Announces Appointment of Sandy Loreaux as CEO
13 Mar 2023 //
BUSINESSWIRE
Bryn Pharma’s UTULY 13.2mg Intranasal Epinephrine Spray Provides Sustained PK
24 Feb 2023 //
BUSINESSWIRE
Bryn Pharma UTULY Phase 3 Data accepted as Late-Breaker at 2023 AAAAI Meeting
15 Feb 2023 //
BUSINESSWIRE
Bryn Pharma Appointments Jeff Hartness to its Board of Directors
13 Dec 2022 //
BUSINESSWIRE
Bryn Pharma Appoints Commercial Veterans Sandy Loreaux and William D. Humphries
29 Nov 2022 //
BUSINESSWIRE
Bryn Celebrates Findings of Food Allergy Collaborative Voice of Patient Report
25 Oct 2022 //
BUSINESSWIRE
Bryn advances anaphylaxis spray after completing pivotal trial
19 Sep 2022 //
FIERCEPHARMA
Bryn Announces Completion of Study Comparing UTULY vs. Epinephrine Autoinjector
13 Sep 2022 //
BUSINESSWIRE
Bryn Pharma Appoints Veteran Anne Clem Whitaker to Its Board of Directors
01 Sep 2021 //
BUSINESSWIRE
Bryn Pharma Multi-Dose Study Of Bi-Dose Epinephrine Nasal Spray For Anaphylaxis
04 Jan 2021 //
PRNEWSWIRE
Bryn Pharma Raises $11 M in Financing to Advance Bi-Dose Epinephrine Nasal Spray
04 Aug 2020 //
PRNEWSWIRE
Bryn Pharma Announces The Publication Of Positive Results From Epinephrine
10 Jun 2020 //
PRNEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.